Tech giants are racing to build businesses that help manage diabetes
For most of the more than 30m people in the US living with diabetes, managing blood sugar is a process of guesswork that involves regular finger pricks and insulin adjustments.
Now, according to a recent CNBCreport, big tech companies — namely Apple, Amazon, and Alphabet — are investing heavily to make those quality continuous treatments more accessible (and capture a big chunk of diabetic business in the process).
Right now, the bar is pretty low
Businesses catering to diabetics have provided an, um, less-than-satisfactory customer experience in recent years: Sellers increased insulin prices as much 353%, and continuous monitoring devices have remained prohibitively expensive.